Rhabdomyosarcoma of the uterus in an adult patient with osteopetrosis: a case report

被引:7
作者
Aminimoghaddam, Soheila [1 ]
Rahbari, Ali [2 ]
Pourali, Roghayeh [3 ]
机构
[1] Iran Univ Med Sci, Firoozgar Hosp, Dept Obstet & Gynecol, Tehran, Iran
[2] Jam Hosp, Dept Pathol, Tehran, Iran
[3] Jam Hosp, Dept Obstet & Gynecol, Fajr St,Motahari St, Tehran 1588657915, Iran
关键词
Rhabdomyosarcoma; Uterus; Sarcoma; PLEOMORPHIC RHABDOMYOSARCOMA; UTERINE;
D O I
10.1186/s13256-021-03172-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Uterine sarcoma accounts for 3-7% of uterine malignant neoplasms. It is more aggressive than epithelial neoplasms, and patients have a poor prognosis. Rhabdomyosarcoma is classified as a heterologous uterine sarcoma. It is the most common soft tissue malignancy in children while rare in adults. In young patients, the majority of genital tract rhabdomyosarcomas occur in vagina; however, the most common site of gynecologic rhabdomyosarcoma is cervix followed by uterine corpus, in adults. Uterine corpus rhabdomyosarcoma is rare in adults. Diagnosis of pure rhabdomyosarcoma in uterus involves widespread and perfect sampling as well as precise histopathological evaluation to uncover any epithelial component. Case presentation Here we report a case of pure rhabdomyosarcoma of uterine corpus in a 60-year-old Iranian postmenopausal female who had osteopetrosis, presenting with 8-month heavy vaginal bleeding and a protruding cervical mass. She is alive on 18-month follow-up after treatment. Conclusions Rhabdomyosarcoma of uterine corpus is rare in adults. Diagnosis of pure rhabdomyosarcoma in uterus involves widespread and perfect sampling as well as precise histopathological evaluation to uncover any epithelial component. Treatment options in adult gynecological rhabdomyosarcoma are based on studies in younger patients, and more studies may help us choose the best approach for improving outcome.
引用
收藏
页数:7
相关论文
共 18 条
[1]   Rhabdomyosarcoma in adults: analysis of treatment modalities in a prospective single-center series [J].
Bergamaschi, Luca ;
Bertulli, Rossella ;
Casanova, Michela ;
Provenzano, Salvatore ;
Chiaravalli, Stefano ;
Gasparini, Patrizia ;
Collini, Paola ;
Sangallis, Claudia ;
Gandola, Lorenza ;
Diletto, Barbara ;
Morosi, Carlo ;
Fiore, Marco ;
Massimino, Maura ;
Ferrari, Andrea .
MEDICAL ONCOLOGY, 2019, 36 (07)
[2]   Revising the WHO classification: female genital tract tumours [J].
Cree, Ian A. ;
White, Valerie A. ;
Indave, B. Iciar ;
Lokuhetty, Dilani .
HISTOPATHOLOGY, 2020, 76 (01) :151-156
[3]   Is fertility-preservation safe for adult non-metastatic gynecologic rhabdomyosarcoma patients? Systematic review and pooled survival analysis of 137 patients [J].
Elsebaie, Maha A. T. ;
Elsayed, Zeinab .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 297 (03) :559-572
[4]   Pleomorphic Rhabdomyosarcoma of the Uterine Corpus: A Clinicopathologic Study of 4 Cases and a Review of the Literature [J].
Fadare, Oluwole ;
Bonvicino, Amanda ;
Martel, Maritza ;
Renshaw, Idris L. ;
Azodi, Masoud ;
Parkash, Vinita .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2010, 29 (02) :122-134
[5]   Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults [J].
Ferguson, Sarah E. ;
Gerald, William ;
Barakat, Richard R. ;
Chi, Dennis S. ;
Soslow, Robert A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (03) :382-389
[6]   Rhabdomyosarcoma in adults - A retrospective analysis of 171 patients treated at a single institution [J].
Ferrari, A ;
Dileo, P ;
Casanova, M ;
Bertulli, R ;
Meazza, C ;
Gandola, L ;
Navarria, P ;
Collini, P ;
Gronchi, A ;
Olmi, P ;
Fossati-Bellani, F ;
Casali, PG .
CANCER, 2003, 98 (03) :571-580
[7]  
HART WR, 1978, AM J CLIN PATHOL, V70, P217
[8]   Uterine Sarcoma - Difficult to Diagnose, Hard to Treat [J].
Mallmann, Peter .
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 (11) :674-674
[9]   Uterine sarcomas [J].
Mbatani, Nomonde ;
Olawaiye, Alexander B. ;
Prat, Jaime .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 143 :51-58
[10]  
MILLER RW, 1995, CANCER, V75, P395, DOI 10.1002/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO